Introducción sesión 1 - Internacionalización de la investigación clínica - JSI2016
•Descargar como PPT, PDF•
0 recomendaciones•174 vistas
Introducción de la sesión 1 sobre Internacionalización de la investigación clínica de las XII Jornadas Salud Investiga celebradas el 28 de noviembre de 2016 en Málaga. Presentación de la moderadora de la mesa: Ana Maria Carriazo Pérez de Guzmán. Consejera Técnica de Relaciones Institucionales. Consejería de Salud. Junta de Andalucía.
Recomendados
Recomendados
Más contenido relacionado
Destacado
Destacado (12)
Último
Último (20)
Introducción sesión 1 - Internacionalización de la investigación clínica - JSI2016
- 1. www.jornadasaludinvestiga.es INTERNACIONALIZACIÓN DE LA INVESTIGACIÓN CLÍNICA Ana Carriazo Consejera Técnica Relaciones Institucionales Consejería de Salud Junta de Andalcía
- 2. Bothwell LE et al. N Engl J Med 2016;374:2175-2181. Locations of RCT Research Sites, 1946–2015.
- 3. Trial site desirability by country. Marta Gehring et al. BMJ Open 2013;3:e002957 ©2013 by British Medical Journal Publishing Group
- 4. Gracias por su atención.
Notas del editor
- Figure 2. Locations of RCT Research Sites, 1946–2015. Trends in the location of published RCTs reflect the British origins of the method and the U.S. enthusiasm for RCTs. After World War II, as the U.S. National Institutes of Health began supporting many trials, the U.S. pharmaceutical industry expanded, and the Kefauver–Harris amendments were passed, large numbers of RCTs were based in the United States. Many trials conducted outside the United States and the United Kingdom were spearheaded by U.S. or U.K. researchers and funders, particularly in the earlier years. As more international regulators began requiring RCTs for drug approval and RCTs increasingly became a global gold standard, trial sponsorship diversified. Data are from Bothwell.3
- Trial site desirability by country. Trial site desirability ‘index’—nine country rank (N=296; ordered by median). Respondents were asked to provide their ‘personal perception’ ranking of the desirability of running trials in nine countries, ranking them from ‘1’ ‘most desirable’ country to ‘9’ ‘least desirable’ country (if needed, they could click ‘no opinion’ in up to three countries they know the least). Data are presented as whisker-box plot of median and lower and upper quartile. There was evidence of a statistically significant difference in the perceived desirability of running trials across European Union countries (p=0.0001).